PEP/NEWS — Peptide intel. Daily.

GLP-1 RECEPTOR AGONISTS REPRESENT THE FASTEST-GROWING CLASS OF METABOLIC PEPTIDE THERAPEUTICS GLOBALLYBPC-157 HAS ACCUMULATED OVER 100 PUBLISHED PRECLINICAL STUDIES ACROSS TISSUE-REPAIR APPLICATIONSEPITALON WAS FIRST SYNTHESIZED BY VLADIMIR KHAVINSON IN THE 1980S FROM BOVINE PINEAL EXTRACTTIRZEPATIDE (A DUAL GIP/GLP-1 AGONIST) PRODUCED AVERAGE WEIGHT LOSS OF 22.5% IN SURMOUNT-1 TRIALTELOMERE LENGTH IS INVERSELY CORRELATED WITH ALL-CAUSE MORTALITY IN MULTIPLE LARGE COHORT STUDIESTB-500 (THYMOSIN BETA-4) IS THE ACTIVE FRAGMENT THOUGHT TO DRIVE MOST OF THE COMPOUND'S REPAIR EFFECTSNAD+ LEVELS DECLINE ROUGHLY 50% BETWEEN AGES 40 AND 60 ACROSS MULTIPLE TISSUE TYPESRETATRUTIDE PHASE 2 DATA SHOWED UP TO 24.2% MEAN WEIGHT REDUCTION AT 48 WEEKS GLP-1 RECEPTOR AGONISTS REPRESENT THE FASTEST-GROWING CLASS OF METABOLIC PEPTIDE THERAPEUTICS GLOBALLYBPC-157 HAS ACCUMULATED OVER 100 PUBLISHED PRECLINICAL STUDIES ACROSS TISSUE-REPAIR APPLICATIONSEPITALON WAS FIRST SYNTHESIZED BY VLADIMIR KHAVINSON IN THE 1980S FROM BOVINE PINEAL EXTRACTTIRZEPATIDE (A DUAL GIP/GLP-1 AGONIST) PRODUCED AVERAGE WEIGHT LOSS OF 22.5% IN SURMOUNT-1 TRIALTELOMERE LENGTH IS INVERSELY CORRELATED WITH ALL-CAUSE MORTALITY IN MULTIPLE LARGE COHORT STUDIESTB-500 (THYMOSIN BETA-4) IS THE ACTIVE FRAGMENT THOUGHT TO DRIVE MOST OF THE COMPOUND'S REPAIR EFFECTSNAD+ LEVELS DECLINE ROUGHLY 50% BETWEEN AGES 40 AND 60 ACROSS MULTIPLE TISSUE TYPESRETATRUTIDE PHASE 2 DATA SHOWED UP TO 24.2% MEAN WEIGHT REDUCTION AT 48 WEEKS

Last updated May 13, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Peter Attia
PETER ATTIA CALLS PEPTIDES 'LEGITIMATE BUT NARROW' IN DEEP-DIVE AMA...

*Attia separates signal from noise across the peptide landscape in a full AMA episode.*

— Peter Attia

Featured Briefs

▶ Video · Peptide-anchored

WHY THEYR'E WRONG ABOUT BPC-157 BEING DANGEROUS - DR TREVOR BACHMEYER

BPC-157: The Research, the Censorship, and Why Big Pharma Can’t Compete In this episode I deliver a direct rebuttal to claims made on recent podcasts proving that BPC-157 is safe, highly effective, and being suppressed because it can’t be

Dr Trevor Bachmeyer
▶ Video

WHY LESS FREQUENT TRT INJECTIONS JUST WORK

💥🚀 Hire me to resolve Libido/EQ/Sensation issues on TRT, HRT, or from the use of 5-AR inhibitors. 💥🚀 📞 🧨💣 Book 1 on 1 coaching with Ryan, and solve Libido/EQ problems on TRT, or from hair loss compounds: https://livecortex.com/trt-s

Cortex Labs
▶ Video

THE ASK DLG SHOW EPISODE #389

The Ask DLG Show Episode #389 is streaming LIVE at 8:30 AM EST! Got health questions this Women's Health Week? It's National Women's Health Week 💖 So many women feel tired before the day starts, experience mood swings, can't sleep, or ju

Dr Livingood
▶ Video · Peptide-anchored

CAN YOU TAKE CJC-1295 BY ITSELF

If you’re wondering whether CJC-1295 works best alone or paired with Ipamorelin, this video breaks down the science behind growth hormone pulses, peptide stacking, and why many people may not be getting the full benefits from their protocol

Regan Archibald

More Headlines